Camberlogo (Camberlogo)
Lamivudine And Zidovudine Tablet, Film Coated
Product Images NDC 71335-0639
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lamivudine And Zidovudine (NDC 71335-0639). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lamivudinestructure (Lamivudinestructure)
Chemical structure of the active ingredient depicted in the image, showing a molecular diagram with nitrogen, oxygen, carbon, hydrogen, and sulfur atoms arranged in a bicyclic structure with a sugar moiety.*
Label Image (Lbl713350639)
Label for Lamivudine and Zidovudine 150 mg/300 mg tablet, film coated, packaged by Bryant Ranch Prepack. The label includes storage instructions to keep tightly closed and store at 20-25°C (68-77°F). It references comparison to Combivir 150 mg/300 mg tablets by Hetero Labs Limited. The label also displays the NDC 71335-0639 and a lot number with barcode.*
Zedovudinechemicalstructure (Zedovudinechemicalstructure)
Chemical structure of the active ingredient shown in the image, depicting a molecular diagram with labeled atoms and bonds consistent with a pharmaceutical compound.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
